Yao Zhengbin — SEC Form 4 filings

SEC reporting owner CIK 1326228. 5 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-07-01 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ALUMIS INC. (ALMS)Director310
ArriVent BioPharma, Inc. (AVBP)President and CEO, Director22

Form 4 filings — Yao Zhengbin

FiledFormIssuerReported transactionsSource
2026-07-024ALUMIS INC. (ALMS)Grant/award (A): 3,553 @ $0 · Grant/award (A): 15,528 (derivative) @ $0EDGAR
2026-02-044ArriVent BioPharma, Inc. (AVBP)Grant/award (A): 550,000 (derivative) @ $0EDGAR
2025-08-014ALUMIS INC. (ALMS)Grant/award (A): 49,800 (derivative) @ $0EDGAR
2025-02-144ArriVent BioPharma, Inc. (AVBP)Grant/award (A): 380,000 (derivative) @ $0EDGAR
2024-07-014ALUMIS INC. (ALMS)Disposition to issuer (D): 23,529 · Grant/award (A): 23,529 · Grant/award (A): 31,016 (derivative) @ $0 · Disposition to issuer (D): 31,016 (derivative) @ $0 · Grant/award (A): 31,016 (derivative) @ $0 · Disposition to issuer (D): 4,278 (derivative) @ $0 · +1 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1326228 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →